Hepatocellular Carcinoma in a Patient with Human Immunodeficiency Virus and Hepatitis B Virus Coinfection: An Emerging Problem?

Southern Medical Journal

Volumn 97, Issue 4, 2004, Pages 401-406

  Hyun, Chris B ^a   Coyle, Walter J ^a  

^a NAVAL MEDICAL CENTER SAN DIEGO   (United States)

Author keywords

Coinfection; Hepatitis B virus; Hepatocellular carcinoma; Human immunodeficiency virus

Indexed keywords

ATENOLOL; DOXORUBICIN; EFAVIRENZ; FLECAINIDE; HEPATITIS B CORE ANTIGEN; IODINATED POPPYSEED OIL; LAMIVUDINE; LAMIVUDINE PLUS ZIDOVUDINE; VIRUS ANTIBODY; ZIDOVUDINE;

ADULT; ANAMNESIS; ARTICLE; CASE REPORT; CLINICAL FEATURE; DIAGNOSTIC PROCEDURE; DISEASE COURSE; DISEASE MARKER; DISEASE TRANSMISSION; HEPATITIS B; HIGH RISK POPULATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; INCIDENCE; INFECTION; LABORATORY TEST; LIVER CELL CARCINOMA; MALE; METASTASIS; MORBIDITY; MORTALITY; PHYSICAL EXAMINATION; RETROVIRUS INFECTION; RISK FACTOR; TREATMENT OUTCOME; VIRUS INFECTION;

ADULT; CARCINOMA, HEPATOCELLULAR; HEPATITIS B; HIV INFECTIONS; HUMANS; LIVER NEOPLASMS; MALE;

EID: 1842680440     PISSN: 00384348     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.SMJ.0000072356.46523.29     Document Type: Article

References (37)

1. Centers for Disease Control and Prevention. Hepatitis B virus: a comprehensive strategy for eliminating transmission in the United States through universal childhood vaccination-Recommendations of the Immunization Practices Advisory Committee (ACIP). MMWR Recomm Rep 1991;40(RR-13):1-25.
2. Befeler AS, Di Bisceglie AM. Hepatitis B. Infect Dis Clin North Am 2000;14:617-632.
3. Coleman PJ, McQuillan GM, Moyer LA, et al. Incidence of hepatitis B virus infection in the United States, 1976-1994: estimates from the National Health and Nutrition Examination Surveys. J Infect Dis 1998; 178:954-959.
4. Hadler SC, Judson FN, O'Malley PM, et al. Outcome of hepatitis B virus infection in homosexual men and its relation to prior human immunodeficiency virus infection. J Infect Dis 1991;163:454-459.
5. Scharschmidt BF, Held MJ, Hollander HH, et al. Hepatitis B in patients with HIV infection: relationship to AIDS and patient survival. Ann Intern Med 1992;117:837-838.
6. Ockenga J, Tillmann HL, Trautwein C, et al. Hepatitis B and C in HIV-infected patients: prevalence and prognostic value. J Hepatol 1997; 27:18-24.
7. Eskild A, Magnus P, Petersen G, et al. Hepatitis B antibodies in HIV-infected homosexual men are associated with more rapid progression to AIDS. AIDS 1992;6:571-574.
8. McDonald MI, Hamilton JD, Durack DT. Hepatitis B surface antigen could harbour the infective agent of AIDS. Lancet 1983;2:882-884.
9. Gilson RJ, Hawkins AE, Beecham MR, et al. Interactions between HIV and hepatitis B virus in homosexual men: effects on the natural history of infection. AIDS 1997;11:597-606.
10. Alka S, Hemlata D, Vaishali C, et al. Hepatitis B virus surface (S) transactivator with DNA-binding properties. J Med Virol 2000;61:1-10.
11. Beasley RP, Hwang LY, Lin CC, et al. Hepatocellular carcinoma and hepatitis B virus: a prospective study of 22,707 men in Taiwan. Lancet 1981;2:1129-1133.
12. Garcia-Samaniego J, Rodriguez M, Berenguer J, et al. Hepatocellular carcinoma in HIV-infected patients with chronic hepatitis C. Am J Gastroenterol 2001;96:179-183.
13. Brockmeyer N, Barthel B. Clinical manifestations and therapies of AIDS associated tumors. Eur J Med Res 1998;3:127-147.
14. Holmberg SD. Possible cofactors for the development of AIDS-related neoplasms. Cancer Detect Prev 1990;14:331-336.
15. Schulz TF, Boshoff CH, Weiss RA. HIV infection and neoplasia. Lancet 1996;348:587-591.
16. Smukler AJ, Ratner L. Hepatitis viruses and hepatocellular carcinoma in HIV-infected patients. Curr Opin Oncol 2002;14:538-542.
17. Martin-Carbonero L, Soriano V, Valencia E, et al. Increasing impact of chronic viral hepatitis on hospital admissions and mortality among HIV-infected patients. AIDS Res Hum Retroviruses 2001;17:1467-1471.
18. Cheney CP, Chopra S, Graham C. Hepatitis C. Infect Dis Clin North Am 2000;14:633-667.
19. Chiaramonte M, Stroffolini T, Vian A, et al. Rate of incidence of hepatocellular carcinoma in patients with compensated viral cirrhosis. Cancer 1999;85:2132-2137.
20. Bonacini, M, Puoti M. Hepatitis C in patients with human immunodeficiency virus infection: diagnosis, natural history, meta-analysis of sexual and vertical transmission, and therapeutic issues. Arch Intern Med 2000; 160;3365:-3373.
21. Housset C, Pol S, Carnot F, et al. Interactions between human immunodeficiency virus-1, hepatitis delta virus and hepatitis B virus infections in 260 chronic carriers of hepatitis B virus. Hepatology 1992;15:578-583.
22. Colin JF, Cazals-Hatem D, Loriot MA, et al. Influence of human immunodeficiency virus infection on chronic hepatitis B in homosexual men. Hepatology 1999;29:1306-1310.
23. Bodsworth N, Donovan B, Nightingale BN. The effect of concurrent human immunodeficiency virus infection on chronic hepatitis B: a study of 150 homosexual men. J Infect Dis 1989;160:577-582.
24. Di Bisceglie AM, Carithers RL Jr, Gores GJ. Hepatocellular carcinoma. Hepatology 1998;28:1161-1165.
25. Lok AS, McMahon BJ. Practice Guidelines Committee, American Association for the Study of Liver Diseases. Chronic hepatitis B. Hepatology 2001;34:1225-1241.
26. Tanaka T, Imamura A, Masuda G, et al. A case of hepatocellular carcinoma in HIV-infected patient. Hepatogastroenterology 1996;43:1067-1072.
27. Cromlish JA. Hepatitis B virus-induced hepatocellular carcinoma: possible roles for HBx. Trends Microbiol 1996;4:270-274.
28. Gomez-Gonzalo M, Carretero M, Rullas J, et al. The hepatitis B virus X protein induces HIV-1 replication and transcription in synergy with T-cell activation signals: functional roles of NF-kappaB/NF-AT and SP1-binding sites in the HIV-1 long terminal repeat promoter. J Biol Chem 2001;276:35435-35443.
29. Lok AS, Heathcote EJ, Hoofnagle JH. Management of hepatitis B: 2000-Summary of a workshop. Gastroenterology 2001;120:1828-1853.
30. Twu JS, Chu K, Robinson WS. Hepatitis B virus X gene activates kappa B-like enhancer sequences in the long terminal repeat of human immunodeficiency virus 1. Proc Natl Acad Sci U S A 1989;86:5168-5172.
31. Barak O, Aronheim A, Shaul Y. HBV X protein targets HIV Tat-binding protein 1. Virology 2001;283:110-120.
32. Vento S, di Perri G, Luzzati R, et al. Clinical reactivation of hepatitis B in anti-HBs-positive patients with AIDS. Lancet 1989;1:332-333 (letter).
33. Lazizi Y, Grangeot-Keros L, Delfraissy JF, et al. Reappearance of hepatitis B virus in immune patients infected with the human immunodeficiency virus type 1. J Infect Dis 1988;158:666-667 (letter).
34. Altfeld M, Rockstroh JK, Addo M, et al. Reactivation of hepatitis B in a long-term anti-HBs-positive patient with AIDS following lamivudine withdrawal. J Hepatol 1998;29:306-309.
35. Perrillo RP. Acute flares in chronic hepatitis B: The natural and unnatural history of an immunologically mediated liver disease. Gastroenterology 2001;120:1009-1022.
36. Mai AL, Yim C, O'Rourke K, et al. The interaction of human immunodeficiency virus infection and hepatitis B virus infection in infected homosexual men. J Clin Gastroenterol 1996;22:299-304.
37. Carr A, Cooper DA. Restoration of immunity to chronic hepatitis B infection in HIV-infected patient on protease inhibitor. Lancet 1997;349: 995-996 (letter).